companies

Semler Scientific Bitcoin Strategy 2026: The Healthcare Company Buying BTC

Semler Scientific (SMLR) became one of the first healthcare companies to adopt Bitcoin as its primary treasury reserve in May 2024. This 2026 profile covers their ~3,200 BTC holdings, the MicroStrategy playbook applied, margin risks, and SMLR vs. direct Bitcoin ownership.

semler scientific bitcoinsmlr bitcoinbitcoin treasury companycorporate bitcoin strategysmall cap bitcoin stockbitcoin corporate treasury

Semler Scientific is a small-cap US healthcare technology company that made headlines in May 2024 by becoming one of the first non-tech public companies to adopt Bitcoin as its primary treasury reserve asset. Led by CEO Doug Murphy-Chutorian, Semler has purchased Bitcoin aggressively, positioning itself alongside MicroStrategy and Metaplanet as a corporate Bitcoin accumulator.

This profile covers Semler's Bitcoin strategy, how much they hold, the business rationale, and what it means for investors.

Who Is Semler Scientific?

Semler Scientific (NASDAQ: SMLR) is a medical technology company based in Santa Clara, California. Their flagship product is QuantaFlo — a point-of-care testing device that measures blood flow to detect peripheral arterial disease (PAD) in patients. The company licenses QuantaFlo to healthcare providers and insurance companies for diagnostic use.

Semler is small: approximately $150M market cap before Bitcoin adoption, with a focused product line and modest growth profile. Their pivot to Bitcoin was unexpected given the company's niche medical focus — which is precisely what made it newsworthy.

Semler's Bitcoin Holdings (2026)

Semler began accumulating Bitcoin in May 2024. As of Q1 2026:

MetricValue
BTC held~3,200 BTC
Average purchase price~$68,000/BTC
Total invested~$218M
Current value (at $85K/BTC)~$272M
Bitcoin as % of total assets~75%

The company has used a combination of operating cash flows, equity raises, and convertible notes to fund Bitcoin purchases. Their Bitcoin holdings now dwarf their core medical device business in dollar terms.

Why Semler Is Buying Bitcoin

Doug Murphy-Chutorian, Semler's CEO, articulated their strategy in a May 2024 shareholder letter: Bitcoin is adopted as a treasury strategy because it is "a reliable store of value and a compelling investment." The board explicitly cited concerns about dollar debasement and viewed Bitcoin as the best available hedge for corporate cash holdings.

The move follows the MicroStrategy template almost exactly:

  1. Adopt Bitcoin as primary treasury reserve asset
  2. Issue equity and/or debt to accelerate accumulation
  3. Report on "Bitcoin yield" (BTC per diluted share) as a key performance metric
  4. Accept increased stock price volatility as a tradeoff for BTC exposure

The MicroStrategy Playbook Applied to Healthcare

Semler's strategy draws explicitly from Michael Saylor's MicroStrategy framework. The key elements:

Bitcoin yield metric: Semler reports BTC per diluted share as a treasury performance metric, similar to how MicroStrategy introduced this. As Bitcoin appreciates faster than new shares are issued, the yield is positive — meaning holders gain Bitcoin exposure without dilution.

At-the-market equity offerings: Semler has raised equity through ATM (at-the-market) programs to fund BTC purchases, accepting dilution in exchange for Bitcoin accumulation. This only makes sense if the buyer believes BTC will outperform the equity dilution cost.

Convertible notes: Issuing convertible debt at low rates to buy Bitcoin creates leveraged BTC exposure — similar to MicroStrategy's early strategy.

Corporate identity shift: Semler is no longer primarily positioned as a medical device company. Investors increasingly price SMLR as a Bitcoin holding vehicle with a medical device business attached.

Semler's Risks

Bitcoin concentration: With ~75% of assets in Bitcoin, Semler's balance sheet lives and dies by BTC price. A severe bear market (Bitcoin -70%) would devastate Semler's asset base and could threaten operating liquidity.

Core business dependency: Unlike MicroStrategy (which generates consistent software license revenue), Semler's QuantaFlo business is highly concentrated with a few large insurance payer clients. Any loss of major contracts would compound the Bitcoin risk.

Dilution risk: Equity raises to fund BTC purchases dilute existing shareholders. If Bitcoin doesn't outperform the cost of dilution, long-term shareholders lose.

Regulatory risk: The SEC has scrutinized companies that dramatically pivot away from their stated business to hold speculative assets. While Bitcoin is now well-established as an institutional asset, the regulatory environment for corporate Bitcoin holders is still evolving.

SMLR vs MSTR vs MSTR-Adjacent Stocks

CompanyBTC HoldingsCore BusinessMarket CapBTC Premium
MicroStrategy (MSTR)~570,000 BTCBusiness software~$90B~2x NAV
Semler Scientific (SMLR)~3,200 BTCMedical tech~$350M~1.3x NAV
Metaplanet (TYO: 3350)~5,000 BTCHotels / investment~$1.5B~1.5x NAV
Boyaa Interactive (HKG)~3,000 BTCGaming~$500M~1.2x NAV

All of these companies trade at a premium to the value of their Bitcoin holdings — the "premium to NAV" reflects investor willingness to pay for the corporate Bitcoin accumulation vehicle. MicroStrategy's premium is the highest because it's the largest and most established.

Semler's smaller premium reflects both its smaller size and the idiosyncratic risk of the medical device core business.

Should Bitcoin Holders Buy SMLR?

Owning SMLR gives you leveraged Bitcoin exposure — when Bitcoin rises, SMLR tends to rise more (because of the NAV premium expansion and market sentiment). But it also means you're paying for:

  • Operational risk (QuantaFlo business concentration)
  • Dilution risk (ongoing equity raises)
  • Premium to NAV (you're paying more than the BTC is worth)
  • Management execution risk

For most Bitcoin holders, owning Bitcoin directly or via IBIT provides cleaner exposure at lower cost and risk. SMLR makes more sense as a high-risk, high-reward Bitcoin equity play for investors who want leveraged exposure and are comfortable with the small-cap volatility.

Bottom Line

Semler Scientific represents the expanding universe of public companies using Bitcoin as their primary treasury strategy. The MicroStrategy playbook is being applied across industries — healthcare, gaming, hotels — by companies looking to transform unremarkable balance sheets into Bitcoin accumulation vehicles.

For Bitcoin enthusiasts, it's a fascinating proof-of-concept. For investors, approach SMLR as a high-beta Bitcoin equity with idiosyncratic small-cap risks attached. Direct Bitcoin ownership remains simpler and cheaper for most.

Related Resources

Stay Up to Date on Bitcoin

Get our free Beginners Guide to Buying Bitcoin plus weekly insights for long-term holders.

Related Posts